DM
ATRS

Deerfield Management’s Antares Pharma, Inc. ATRS Stock Holding History

Deerfield Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,983,440
Closed -$4.82M – 118
2015
Q4 		$4.82M Sell
3,983,440
-11,467,684
-74% -$16M 0.2% 84
2015
Q3 		$26.3M Sell
15,451,124
-2,938,665
-16% -$5.76M 1.02% 40
2015
Q2 		$38.3M Buy
18,389,789
+6,311,471
+52% +$15.3M 1.27% 22
2015
Q1 		$32.7M Buy
12,078,318
+3,974,000
+49% +$10.1M 1.06% 26
2014
Q4 		$20.8M Buy
8,104,318
+280,700
+4% +$631K 0.75% 37
2014
Q3 		$14.3M Sell
7,823,618
-1,780,085
-19% -$3.88M 0.52% 57
2014
Q2 		$25.6M Buy
9,603,703
+115,242
+1% +$347K 1.03% 32
2014
Q1 		$33.2M Sell
9,488,461
-652,713
-6% -$2.9M 1.36% 24
2013
Q4 		$45.3M Buy
10,141,174
+1,488,055
+17% +$6.06M 2.35% 10
2013
Q3 		$35.1M Sell
8,653,119
-746,881
-8% -$3.26M 1.63% 17
2013
Q2 		$39.1M Buy
+9,400,000
New +$36.3M 1.84% 17

Other funds holding ATRS

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deerfield Management's ATRS Position: Q1 2016 in Review

Deerfield Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2016, closing a stake of 3,983,440 shares — an estimated $4.82M sold.

Deerfield Management first reported a position in ATRS in Q2 2013 and held it in 11 quarters. The position peaked at $45.3M in Q4 2013. 83 funds tracked by Wall St. Rank hold ATRS as of Q1 2016.

  • Deerfield Management reported no remaining Antares Pharma, Inc. position as of Q1 2016 after selling out during the quarter.
  • Deerfield Management sold 3,983,440 Antares Pharma, Inc. shares in Q1 2016, an estimated $4.82M.
  • Deerfield Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 11 quarters.
  • Deerfield Management's Antares Pharma, Inc. position peaked at $45.3M in Q4 2013.
  • 83 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2016.

Based on Deerfield Management's 13F filing for Q1 2016, filed 16 May 2016.